Physicochemical Properties
| Molecular Formula | C32H58N11O14P3S |
| Molecular Weight | 945.8545 |
| Exact Mass | 945.309 |
| CAS # | 1800401-93-7 |
| PubChem CID | 118704767 |
| Appearance | White to off-white solid powder |
| Density | 1.8±0.1 g/cm3 |
| Index of Refraction | 1.730 |
| LogP | -3.53 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 22 |
| Rotatable Bond Count | 27 |
| Heavy Atom Count | 61 |
| Complexity | 1590 |
| Defined Atom Stereocenter Count | 7 |
| SMILES | CN(CCCCN(C)CCCNP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)CCCNC(=O)CCCC[C@H]4[C@@H]5[C@H](CS4)NC(=O)N5 |
| InChi Key | MODMQMYTNMWWCS-MCINONILSA-N |
| InChi Code | InChI=1S/C32H58N11O14P3S/c1-41(15-7-11-34-24(44)10-4-3-9-23-25-21(18-61-23)39-32(47)40-25)13-5-6-14-42(2)16-8-12-38-58(48,49)56-60(52,53)57-59(50,51)54-17-22-27(45)28(46)31(55-22)43-20-37-26-29(33)35-19-36-30(26)43/h19-23,25,27-28,31,45-46H,3-18H2,1-2H3,(H,34,44)(H,50,51)(H,52,53)(H2,33,35,36)(H2,38,48,49)(H2,39,40,47)/t21-,22+,23-,25-,27+,28+,31+/m0/s1 |
| Chemical Name | N-[3-[4-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propyl-methylamino]butyl-methylamino]propyl]-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxyphosphonamidic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | PKA kinase and myelin basic protein (MBP), the full-length protein substrate, were treated with ATP-polyamine-biotin (APB). Kinase was required for the detection of biotinylation. Additionally, in the presence of the kinase inhibitor staurosporine, in the absence of ATP-polyamine-biotin, or during acid incubation, MBP biotinylation is lost as a result of cleavage of the phosphoramidate bond. It is only in the presence of APB co-substrate that the biotinylated Kemp peptide product is detected [1]. |
| References |
[1]. A Cell-Permeable ATP Analogue for Kinase-Catalyzed Biotinylation. Angew Chem Int Ed Engl. 2015 Aug 10;54(33):9618-21. |
Solubility Data
| Solubility (In Vitro) | H2O : ~6 mg/mL (~6.34 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 7.69 mg/mL (8.13 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with heating and sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.0573 mL | 5.2863 mL | 10.5725 mL | |
| 5 mM | 0.2115 mL | 1.0573 mL | 2.1145 mL | |
| 10 mM | 0.1057 mL | 0.5286 mL | 1.0573 mL |